Boston Scientific Adds Another Product To Its Portfolio

The S-ICD is implanted in patients who are prone to sudden cardiac arrests caused by heart rhythm disorder. In a standard S-ICD system, the leads of the defibrillator do not touch the heart. This reduces the risks associated with conventional transvenous implantable cardioverter-defibrillators (T-ICDs) including blood infection and lead replacement. The EMBLEM S-ICD will be launched in a limited market in certain European health institutions, which will be followed by a wider release of the prod...